Cadila Healthcare Ltd - 532321 - Notification
Manufacturing facility of Alidac Pharmaceuticals Limited, 100% subsidiary of Cadila Healthcare Limited received an Establishment Inspection Report (EIR)15-06-2019
15-06-2019
Cadila Healthcare Ltd - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificates10-06-2019
Riding on Heinz, Zydus Wellness eyes Rs 4,500-crore turnover in 5 years
Consumer business crucial for Cadila Healthcare, at a time when US and India have pricing pressure05-06-2019
Cadila Healthcare net profit rises 4.11% to Rs 1,849 crore in FY19; board declares dividend of Rs 3.50 per share
Cadila Q4 consolidated net profit declines 22.1% year-on-year to Rs 460 crore, while revenue climbed 15.3 per cent to Rs 3,771.2 crore compared to the same quarter last year29-05-2019
CADILA HEALTHCARE LTD. - 532321 - Book Closure Dates For AGM And Dividend Is From July 29, 2019 To August 9, 2019.
Book Closure Dates for AGM and Dividend is from July 29, 2019 to August 9, 2019.29-05-2019
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Dividend Updates
Board of Directors recommended dividend of Rs. 3.50/- (350%) per equity share of Re. 1/- each for the financial year 2018-2019, subject to approval of the shareholders at the ensuing Annual General Meeting.29-05-2019
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Date of payment of Dividend
Date of payment of dividend is on and from August 14, 2019.29-05-2019
CADILA HEALTHCARE LTD. - 532321 - Board recommends Dividend
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 29, 2019, inter alia, have recommended a dividend of Rs. 3.50 [@ 350%] per equity share on 1,023,742,600 equity shares of Re. 1/-each for the financial year ended on March 31, 2019. The recommended dividend is subject to the approval of the shareholders at the ensuing Annual General Meeting.29-05-2019